Literature DB >> 22391613

The impact of frailty and delirium on mortality in older inpatients.

Eamonn M P Eeles1, Susan V White, Sinead M O'Mahony, Antony J Bayer, Ruth E Hubbard.   

Abstract

BACKGROUND: delirium and frailty are common among hospitalised older people but delirium is often missed and frailty considered difficult to measure in clinical practice.
OBJECTIVE: to explore the relationship between delirium and frailty in older inpatients and determine their impact on survival. DESIGN AND
SETTING: the prospective cohort study of 273 patients aged ≥75 years. MEASURES: patients were screened for delirium at presentation and on alternate days throughout their hospital stay. Frailty status was measured by an index of accumulated deficits (FI), giving a potential score from 0 (no deficits) to 1.0 (all 33 deficits), with 0.25 used as the cut-off between 'fit' and 'frail'.
RESULTS: delirium was detected in 102 patients (mean FI: 0.33) and excluded in 171 (mean FI: 0.18) (P < 0.005); 111 patients were frail. Among patients with delirium, the median survival in fit patients was 359 days (95% CI: 118-600) compared with 88 days for those who were frail (95% CI: 5-171; P < 0.05).
CONCLUSION: delirium was associated with higher levels of frailty: the identification of frail patients may help to target those at a greatest risk of delirium. Survival following delirium was poor with the combination of frailty and delirium conferring a particularly bleak prognosis.

Entities:  

Mesh:

Year:  2012        PMID: 22391613     DOI: 10.1093/ageing/afs021

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  51 in total

Review 1.  Preoperative Cognitive and Frailty Screening in the Geriatric Surgical Patient: A Narrative Review.

Authors:  Michael S Axley; Katie J Schenning
Journal:  Clin Ther       Date:  2015-11-25       Impact factor: 3.393

2.  Feasibility and Rationale for Incorporating Frailty and Cognitive Screening Protocols in a Preoperative Anesthesia Clinic.

Authors:  Shawna Amini; Samuel Crowley; Loren Hizel; Franchesca Arias; David J Libon; Patrick Tighe; Chris Giordano; Cynthia W Garvan; F Kayser Enneking; Catherine C Price
Journal:  Anesth Analg       Date:  2019-09       Impact factor: 5.108

3.  Treating older people.

Authors:  Ken Woodhouse
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

Review 4.  Sarcopenia and frailty in chronic respiratory disease.

Authors:  Anna E Bone; Nilay Hepgul; Samantha Kon; Matthew Maddocks
Journal:  Chron Respir Dis       Date:  2017-02-24       Impact factor: 2.444

Review 5.  Age-related hearing impairment-a risk factor and frailty marker for dementia and AD.

Authors:  Francesco Panza; Vincenzo Solfrizzi; Giancarlo Logroscino
Journal:  Nat Rev Neurol       Date:  2015-02-17       Impact factor: 42.937

6.  Resilience in Aging Mice.

Authors:  James L Kirkland; Michael B Stout; Felipe Sierra
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-08-16       Impact factor: 6.053

Review 7.  Non-pharmacological approaches in the prevention of delirium.

Authors:  Fabio Salvi; John Young; Moira Lucarelli; Alessandra Aquilano; Riccardo Luzi; Giuseppina Dell'Aquila; Antonio Cherubini
Journal:  Eur Geriatr Med       Date:  2020-01-02       Impact factor: 1.710

8.  Delirium is a predictor of in-hospital mortality in elderly patients with community acquired pneumonia.

Authors:  Filippo Pieralli; Vieri Vannucchi; Antonio Mancini; Maddalena Grazzini; Giulia Paolacci; Alessandro Morettini; Carlo Nozzoli
Journal:  Intern Emerg Med       Date:  2013-09-19       Impact factor: 3.397

Review 9.  Global frailty: The role of ethnicity, migration and socioeconomic factors.

Authors:  Zeinab Majid; Carly Welch; Justine Davies; Thomas Jackson
Journal:  Maturitas       Date:  2020-05-24       Impact factor: 4.342

Review 10.  Medication prescribing in frail older people.

Authors:  Ruth E Hubbard; M Sinead O'Mahony; Kenneth W Woodhouse
Journal:  Eur J Clin Pharmacol       Date:  2012-09-11       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.